ATRC - AtriCure Inc. (ATRC) Q4 2023 Earnings Call Transcript
2024-02-15 22:30:04 ET
AtriCure, Inc. (ATRC)
Q4 2023 Earnings Conference Call
February 15, 2024, 16:30 PM ET
Company Participants
Marissa Bych - Gilmartin Group, Investor Relations
Michael Carrel - President and Chief Executive Officer
Angela Wirick - Chief Financial Officer
Conference Call Participants
Robbie Marcus - JP Morgan
Simon Negin - UBS
Matthew O’Brien - Piper Sandler
Sam Eiber - BTIG
Joseph Conway - Needham
Daniel Stauder - JMP
Suraj Kalia - Oppenheimer & Company
Presentation
Operator
Good afternoon, and welcome to AtriCure’s Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of today’s call. As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to Marissa Bych, the Gilmartin Group for a few introductory comments.
Marissa Bych
Great. Thank you, and good afternoon. By now, you should have received a copy of the earnings press release. If you have not received a copy, please call 513-644-4484 to have one e-mail to you.
Before we begin, let me remind you that the company’s remarks include forward-looking statements. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond AtriCure’s control, including risks and uncertainties described from time to time in AtriCure's SEC filings.
These statements include, but are not limited to, financial expectations and guidance, expectations regarding the potential market opportunity for AtriCure’s franchises and growth initiatives, future product approvals, clearances, reimbursement and clinical trial outcomes. AtriCure’s results may differ materially from those projected. AtriCure undertakes no obligation to publicly update any forward-looking statements.
Additionally, we refer to non-GAAP financial measures, specifically revenue reported on a constant currency basis, adjusted EBITDA and adjusted loss per share. A reconciliation of these non-GAAP financial measures with the most directly comparable GAAP measures is included in our press release, which is available on our website....
AtriCure, Inc. (ATRC) Q4 2023 Earnings Call Transcript